tiprankstipranks
Advertisement
Advertisement

DE:AMG Stock Latest News

Amgen price target raised to $326 from $309 at Morgan Stanley
The FlyAmgen price target raised to $326 from $309 at Morgan Stanley
4h ago
AMGN
Amgen price target raised to $351 from $347 at Guggenheim
PremiumThe Fly
Amgen price target raised to $351 from $347 at Guggenheim
1d ago
AMGN
Amgen: Long-Term AI Potential but Limited Near-Term Upside Supports Hold Rating
PremiumRatings
Amgen: Long-Term AI Potential but Limited Near-Term Upside Supports Hold Rating
1d ago
AMGN
Amgen price target raised to $325 from $319 at Truist
PremiumThe Fly
Amgen price target raised to $325 from $319 at Truist
2d ago
AMGN
Viridian Therapeutics price target lowered to $36 from $40 at Truist
PremiumThe Fly
Viridian Therapeutics price target lowered to $36 from $40 at Truist
2d ago
AMGN
VRDN
Amgen price target raised to $325 from $319 at Truist
PremiumThe FlyAmgen price target raised to $325 from $319 at Truist
2d ago
AMGN
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
Premium
The Fly
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
2d ago
AMGN
VRDN
Amgen put volume heavy and directionally bearish
Premium
The Fly
Amgen put volume heavy and directionally bearish
3d ago
AMGN
Amgen price target raised to $370 from $360 at RBC Capital
PremiumThe Fly
Amgen price target raised to $370 from $360 at RBC Capital
3d ago
AMGN
Leerink sees weakness in Viridian Therapeutics shares as ‘overdone’
PremiumThe Fly
Leerink sees weakness in Viridian Therapeutics shares as ‘overdone’
4d ago
AMGN
VRDN
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
PremiumThe Fly
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
4d ago
WW
AMC
Stifel sees path towards differentiation for Viridian after Amgen data
PremiumThe Fly
Stifel sees path towards differentiation for Viridian after Amgen data
4d ago
AMGN
VRDN
Amgen announces ‘positive’ results from Phase 3 trial of tepezza
PremiumThe FlyAmgen announces ‘positive’ results from Phase 3 trial of tepezza
4d ago
AMGN
Evercore cuts Viridian price target, removes from ‘Tactical Outperform’ list
Premium
The Fly
Evercore cuts Viridian price target, removes from ‘Tactical Outperform’ list
8d ago
AMGN
VRDN
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
Premium
The Fly
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
9d ago
AMGN
ZLAB
FDA identifies cases of serious liver injury in patients taking Tavneos
PremiumThe Fly
FDA identifies cases of serious liver injury in patients taking Tavneos
10d ago
AMGN
Amgen announces data on Repatha from Phase 3 Vesalius-CV trial
PremiumThe Fly
Amgen announces data on Repatha from Phase 3 Vesalius-CV trial
12d ago
AMGN
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
22d ago
AMGN
REGN
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $390 from $375 at Wells Fargo
22d ago
AMGN
REGN
Amgen initiated with a Hold at Jefferies
PremiumThe FlyAmgen initiated with a Hold at Jefferies
1M ago
AMGN
Kyowa Kirin announces discontinuation of rocatinlimab clinical trials
Premium
The Fly
Kyowa Kirin announces discontinuation of rocatinlimab clinical trials
1M ago
AMGN
Private Markets: World Labs raises $1B in new funding
Premium
The Fly
Private Markets: World Labs raises $1B in new funding
1M ago
U
BX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >